Ticker Symbol: ALKS
Alkermes plc
$23.61 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001520262
Company Profile
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: alkermes.com
CEO: Richard F. Pops
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $27.02
Change:
$0.21
(
0.78%)
Days Range: $26.82 - $27.27
Beta: 0.44
52wk. High: $33.71
52wk. Low: $21.76
Ytd. Change 4.19%
50 Day Moving Average: $28.75
200 Day Moving Average: $29.61
Shares Outstanding: 166558735
Valuation
Market Cap: 450.0B
PE Ratio: 43.58
EPS (TTM): 0.62
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A